NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,905 | +3.5% | 11,594 | 0.0% | 0.00% | – |
| Q2 2023 | $6,669 | -18.2% | 11,594 | 0.0% | 0.00% | – |
| Q1 2023 | $8,149 | -68.9% | 11,594 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $26,202 | -88.0% | 11,594 | -83.0% | 0.00% | -83.3% |
| Q3 2022 | $219,000 | -20.9% | 68,388 | -6.2% | 0.01% | -25.0% |
| Q2 2022 | $277,000 | -29.9% | 72,888 | -0.5% | 0.01% | -11.1% |
| Q1 2022 | $395,000 | -60.0% | 73,281 | +0.3% | 0.01% | -60.9% |
| Q4 2021 | $987,000 | +235.7% | 73,055 | +346.5% | 0.02% | +187.5% |
| Q3 2021 | $294,000 | -93.5% | 16,362 | -93.9% | 0.01% | -96.0% |
| Q4 2020 | $4,532,000 | – | 266,559 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |